Search results
Current Drug Targets aims to cover developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. receptors, enzymes, genes.
- Subscribe
Researchers can access related articles from current and...
- Advertise With Us
Bentham is offering subject-based scholarly content...
- Editorial Board
He has published more than 200 scientific publications and...
- About Journal
Aims & Scope. Current Drug Targets aims to cover the latest...
- Editor's Choice
Editor's Choice - Current Drug Targets | Bentham Science
- Thematic Issues
Thematic Issues - Current Drug Targets | Bentham Science
- Most Accessed Articles
Most Accessed Articles - Current Drug Targets | Bentham...
- Free Online Copy
Free Online Copy - Current Drug Targets | Bentham Science
- Subscribe
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Current Cancer Drug Targets publishes original research articles, letters/commentary/perspectives, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.
5 days ago · Read latest issue. More opportunities to publish your research: Browse open Calls for Papers. Read the latest articles of Current Cancer Drug Targets at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature.
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Dec 2, 2016 · Here, Overington and colleagues present a comprehensive map of the molecular targets of approved drugs, and explore aspects including the footprint of target classes across disease areas, the...
1 day ago · A MEDLINE-indexed journal covering novel molecular disease targets while providing expert opinion on their scope for future drug development and the impact on drug discovery. Content evaluates molecules, signaling pathways, receptors, and other therapeutic targets.
